Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-01-22FDA Approved: OLANZAPINE — Supplemental Application (Modavar Pharmaceuticals LLC)
The FDA approved Modavar Pharmaceuticals LLC's supplemental application to market a generic olanzapine product.
-
FDA approval · 2026-01-16FDA Approved: RYKINDO EXTENDED-RELEASE MICROSPHERES — Supplemental Application (Shandong Luye Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for RyKindo Extended-Release Microspheres, a new extended-release formulation of risperidone develop…
-
FDA approval · 2026-01-14FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for a fixed-dose combination of olanzapine and fluoxetine, enabling generic marketing of the pr…
-
EMA approval · 2026-01-12EMA Authorised: Latuda (lurasidone) — Aziende Chimiche Riunite Angelini Francesco S.p.A.
The European Medicines Agency authorised Latuda (lurasidone) for schizophrenia, with Aziende Chimiche Riunite Angelini Francesco S.p.A. as t…
-
EMA approval · 2026-01-12EMA Authorised: Abilify (aripiprazole) — Otsuka Pharmaceutical Netherlands B.V.
The EMA authorised Abilify (aripiprazole) by Otsuka Pharmaceutical Netherlands B.V. for schizophrenia and bipolar disorder in the European U…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-01-08EMA Authorised: Reagila (cariprazine hydrochloride) — Gedeon Richter
The European Medicines Agency authorised Reagila (cariprazine) for schizophrenia, with Gedeon Richter as the marketing authorisation holder …
-
EMA approval · 2026-01-07EMA Authorised: Olanzapine Viatris (previously Olanzapine Mylan) (olanzapine) — Viatris Limited
The EMA has authorised Olanzapine Viatris for schizophrenia and bipolar disorder; the marketing authorization holder is Viatris Limited.
-
FDA approval · 2026-01-07FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s supplemental application for quetiapine (generic), indicating approval of a modification to an alr…
-
FDA approval · 2026-01-06FDA Approved: OLANZAPINE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Olanzapine submitted by Strides Pharma Science Limited. This action approves a supplemental …
-
FDA approval · 2026-01-06FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Olanzapine by Macleods Pharmaceuticals Limited, supporting a generic version of the drug.
-
FDA approval · 2026-01-05FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for HALOPERIDOL DECANOATE from BluePoint Laboratories. This approval supports the continued authoriz…
-
FDA approval · 2025-12-18FDA Approved: HALOPERIDOL — Original Application (Creekwood Pharmaceuticals LLC)
FDA approved Creekwood Pharmaceuticals' generic haloperidol under an original ANDA (ANDA 218162).
-
FDA approval · 2025-12-03FDA Approved: OLANZAPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for olanzapine from Torrent Pharmaceuticals Limited (ANDA 091415), expanding access to a generic ola…
-
FDA approval · 2025-11-18FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic fluphenazine hydrochloride under an ANDA, expanding access to this antipsychotic used to treat …
-
FDA approval · 2025-11-05FDA Approved: CAPLYTA — Supplemental Application (Intra-Cellular Therapies, Inc)
FDA approves a supplemental application for CAPLYTA (lumateperone) from Intra-Cellular Therapies, Inc.
-
FDA approval · 2025-11-04FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for RISPERIDONE from Amneal Pharmaceuticals LLC under an ANDA, authorizing a new or updated generic …
-
EMA approval · 2025-10-28EMA Authorised: Abilify Maintena (aripiprazole) — Otsuka Pharmaceutical Netherlands B.V.
The European Medicines Agency authorised Abilify Maintena (aripiprazole) with Otsuka Pharmaceutical Netherlands B.V. as the marketing author…
-
FDA approval · 2025-10-23FDA Approved: OLANZAPINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for olanzapine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2025-10-22FDA Approved: ARIPIPRAZOLE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved the original application for aripiprazole from Quagen Pharmaceuticals LLC, marking the availability of a generic aripiprazole p…
-
EMA approval · 2025-10-14EMA Authorised: Okedi (risperidone) — Laboratorios Farmacéuticos Rovi, S.A.
The European Medicines Agency authorised Okedi, a risperidone product, for the treatment of schizophrenia.
-
EMA approval · 2025-10-09EMA Authorised: Adasuve (loxapine) — Ferrer Internacional S.A.
The EMA authorised Adasuve (loxapine) by Ferrer Internacional S.A. for use in schizophrenia and bipolar disorder.
-
FDA approval · 2025-09-17FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for ziprasidone from Dr. Reddy's Laboratories Limited, indicating regulatory action on an existi…
-
FDA approval · 2025-09-17FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Ziprasidone hydrochloride submitted by Apotex Corp., for an already approved generic product. Th…
-
FDA approval · 2025-09-12FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
The FDA approved a supplemental application for HALOPERIDOL DECANOATE submitted by Meitheal Pharmaceuticals Inc., expanding the regulatory a…
-
FDA approval · 2025-09-12FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA granted a supplemental approval for a generic quetiapine fumarate product from Hikma Pharmaceuticals USA Inc. (ANDA 090749). The approva…